166 related articles for article (PubMed ID: 38412549)
1. Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease.
Brokate-Llanos AM; Sanchez-Ibañez M; Pérez-Jiménez MM; Monje-Moreno JM; Gómez-Marín C; Caro C; Vivar-Rios C; Moreno-Mateos MA; García-Martín ML; Muñoz MJ; Royo JL
G3 (Bethesda); 2024 May; 14(5):. PubMed ID: 38412549
[TBL] [Abstract][Full Text] [Related]
2. A novel assay revealed that ribonucleotide reductase is functionally important for interstrand DNA crosslink repair.
Fujii N; Evison BJ; Actis ML; Inoue A
Bioorg Med Chem; 2015 Nov; 23(21):6912-21. PubMed ID: 26462050
[TBL] [Abstract][Full Text] [Related]
3. Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.
Jørgensen CL; Ejlertsen B; Bjerre KD; Balslev E; Nielsen DL; Nielsen KV
BMC Cancer; 2013 Nov; 13():541. PubMed ID: 24215511
[TBL] [Abstract][Full Text] [Related]
4. Understanding ribonucleotide reductase inactivation by gemcitabine.
Cerqueira NM; Fernandes PA; Ramos MJ
Chemistry; 2007; 13(30):8507-15. PubMed ID: 17636467
[TBL] [Abstract][Full Text] [Related]
5. 3-Hydroxyanthranilic Acid Delays Paralysis in
Hull BT; Miller KM; Corban C; Backer G; Sheehan S; Korstanje R; Sutphin GL
Biomolecules; 2024 May; 14(5):. PubMed ID: 38786006
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine.
Pereira S; Fernandes PA; Ramos MJ
J Comput Chem; 2004 Jul; 25(10):1286-94. PubMed ID: 15139041
[TBL] [Abstract][Full Text] [Related]
7. Cratoxylum formosum Extract Protects against Amyloid-Beta Toxicity in a Caenorhabditis elegans Model of Alzheimer's Disease.
Keowkase R; Weerapreeyakul N
Planta Med; 2016 Apr; 82(6):516-23. PubMed ID: 26845710
[TBL] [Abstract][Full Text] [Related]
8. mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer.
Tian L; Chen C; Guo Y; Zhang F; Mi J; Feng Q; Lin S; Xi N; Tian J; Yu L; Chen Y; Cao M; Lai C; Fan J; Zhang Y; Chen G
Neoplasia; 2021 Jul; 23(7):643-652. PubMed ID: 34126361
[TBL] [Abstract][Full Text] [Related]
9. Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer.
Bennett CN; Tomlinson CC; Michalowski AM; Chu IM; Luger D; Mittereder LR; Aprelikova O; Shou J; Piwinica-Worms H; Caplen NJ; Hollingshead MG; Green JE
Breast Cancer Res; 2012 Jul; 14(4):R109. PubMed ID: 22812567
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-beta (Aβ1-42)-induced paralysis in Caenorhabditis elegans is reduced by restricted cholesterol supply.
Regitz C; Wenzel U
Neurosci Lett; 2014 Jul; 576():93-6. PubMed ID: 24909620
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.
Regitz C; Dußling LM; Wenzel U
Mol Nutr Food Res; 2014 Oct; 58(10):1931-40. PubMed ID: 25066301
[TBL] [Abstract][Full Text] [Related]
12. Monascin from Monascus-Fermented Products Reduces Oxidative Stress and Amyloid-β Toxicity via DAF-16/FOXO in Caenorhabditis elegans.
Shi YC; Pan TM; Liao VH
J Agric Food Chem; 2016 Sep; 64(38):7114-20. PubMed ID: 27554775
[TBL] [Abstract][Full Text] [Related]
13. Diphenyl-diselenide suppresses amyloid-β peptide in Caenorhabditis elegans model of Alzheimer's disease.
Zamberlan DC; Arantes LP; Machado ML; Golombieski R; Soares FA
Neuroscience; 2014 Oct; 278():40-50. PubMed ID: 25130558
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol reduces amyloid-beta (Aβ₁₋₄₂)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans.
Regitz C; Fitzenberger E; Mahn FL; Dußling LM; Wenzel U
Eur J Nutr; 2016 Mar; 55(2):741-747. PubMed ID: 25851110
[TBL] [Abstract][Full Text] [Related]
15. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
Wang C; Saar V; Leung KL; Chen L; Wong G
Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
[TBL] [Abstract][Full Text] [Related]
16. The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent.
Sigmond J; Kamphuis JA; Laan AC; Hoebe EK; Bergman AM; Peters GJ
Biochem Pharmacol; 2007 May; 73(10):1548-57. PubMed ID: 17324380
[TBL] [Abstract][Full Text] [Related]
17. Rose Essential Oil Delayed Alzheimer's Disease-Like Symptoms by SKN-1 Pathway in C. elegans.
Zhu S; Li H; Dong J; Yang W; Liu T; Wang Y; Wang X; Wang M; Zhi D
J Agric Food Chem; 2017 Oct; 65(40):8855-8865. PubMed ID: 28915354
[TBL] [Abstract][Full Text] [Related]
18. A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance.
Zhou B; Su L; Hu S; Hu W; Yip ML; Wu J; Gaur S; Smith DL; Yuan YC; Synold TW; Horne D; Yen Y
Cancer Res; 2013 Nov; 73(21):6484-93. PubMed ID: 24072748
[TBL] [Abstract][Full Text] [Related]
19. A deuterohemin peptide protects a transgenic Caenorhabditis elegans model of Alzheimer's disease by inhibiting Aβ
Xu J; Yuan Y; Zhang R; Song Y; Sui T; Wang J; Wang C; Chen Y; Guan S; Wang L
Bioorg Chem; 2019 Feb; 82():332-339. PubMed ID: 30428413
[TBL] [Abstract][Full Text] [Related]
20. HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma.
Jones RJ; Baladandayuthapani V; Neelapu S; Fayad LE; Romaguera JE; Wang M; Sharma R; Yang D; Orlowski RZ
Blood; 2011 Oct; 118(15):4140-9. PubMed ID: 21844567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
